Why It Matters
Access Bio Inc., a diagnostics company, registered with the lobbying firm Steptoe LLP on July 27 to advocate on health issues. The company's CareStart malaria Rapid Diagnostic Tests (RDTs) are recognized as one of the world's leading brands in malaria testing.
Broader Context
In April 2025, the World Health Organization warned that malaria progress was in jeopardy amid foreign aid cuts enacted by the Trump administration. More than 40% of planned insecticide-treated bed net distribution campaigns designed to reach 425 million people were either delayed or at risk due to those cuts. In one Nigerian state, rapid diagnostic tests plummeted from approximately 21,000 per quarter to roughly 700 in one quarter of 2025 following United States Agency for International Development (USAID) funding reductions.
Taylor M. Bush, a government affairs professional at the firm, is listed on the registration. The lobbying income total for the partnership is currently listed at $0.
Access the Legis1 platform for comprehensive political news, data, and insights.
Spot something wrong? Report an issue with this article